Evidence map›Paper›PMID 42521435›Full record

ArticleBMJ case reports2026

Oral malignant melanoma of the tongue with suspected intralingual in-transit metastasis.

Reon Morioka, Masako Fujioka-Kobayashi, Hiroto Tatsumi, Yuhei Matsuda, Rie Osako-Sonoyama, Michitaka Somoto, Takahiro Kanno

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Reon MoriokaDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
Masako Fujioka-KobayashiDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
Hiroto TatsumiDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
Yuhei MatsudaDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
Rie Osako-SonoyamaDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
Michitaka SomotoDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
Takahiro KannoDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan tkanno@med.shimane-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral malignant melanoma (OMM) is a rare and aggressive malignancy, and involvement of the tongue is particularly uncommon. We report a case presenting with two isolated pigmented tongue lesions clinically resembling benign conditions. Excisional biopsy of the anterior lesion confirmed melanoma, and the tongue base lesion was clinically suspected to represent possible in-transit metastasis. To our knowledge, in-transit metastasis in OMM is not well documented. The patient underwent wide local excision followed by adjuvant pembrolizumab based on cutaneous melanoma guidelines. Final pathological staging was pT3b pN1c cM0 (stage IIIC). At 1-year follow-up, no recurrence or metastasis was observed and oral function was preserved with a palatal augmentation prosthesis. This case highlights diagnostic challenges and the importance of early biopsy and multidisciplinary management. Additional cases and further multicentre studies are needed to validate these observations and guide the development of standardised treatment protocols in the diagnosis and management of OMM.

Indexed as

MelanomaSkin NeoplasmsTongue NeoplasmsAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalDiagnosis, DifferentialHumansAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalpembrolizumabDentistry and oral medicineHead and neck cancerImmune Checkpoint InhibitorsMouthNutritional support

Identifiers

PMID42521435
PMCPMC13422245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.